Skip to main content
Fig. 2 | Cell & Bioscience

Fig. 2

From: The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data

Fig. 2

A: Venn diagram showing the intersection of differential genes with consistent expression trends in residual tumor cells after neoadjuvant chemotherapy for LUAD, ESCC, and cisplatin-resistant cell lines; B: Expression of 12 genes in tumor cells before and after neoadjuvant therapy for lung adenocarcinoma; C: Expression of 12 genes in tumor cells before and after neoadjuvant therapy for ECC

Back to article page